HSD17B12
Very-long-chain 3-oxoacyl-CoA reductase
Also known as: DHB12_HUMAN, KAR, SDR12C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q53GQ0
- Gene
- HSD17B12
- Ensembl
- ENSG00000149084
- Chromosome
- 11
- Canonical length
- 312 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene encodes a very important 17beta-hydroxysteroid dehydrogenase (17beta-HSD) that converts estrone into estradiol in ovarian tissue. This enzyme is also involved in fatty acid elongation. [provided by RefSeq, Oct 2011]
Canonical amino-acid sequenceUniProt
312 residues, UniProt reviewed canonical sequence.
>Q53GQ0|HSD17B12
1 MESALPAAGF LYWVGAGTVA YLALRISYSL FTALRVWGVG NEAGVGPGLG EWAVVTGSTD
61 GIGKSYAEEL AKHGMKVVLI SRSKDKLDQV SSEIKEKFKV ETRTIAVDFA SEDIYDKIKT
121 GLAGLEIGIL VNNVGMSYEY PEYFLDVPDL DNVIKKMINI NILSVCKMTQ LVLPGMVERS
181 KGAILNISSG SGMLPVPLLT IYSATKTFVD FFSQCLHEEY RSKGVFVQSV LPYFVATKLA
241 KIRKPTLDKP SPETFVKSAI KTVGLQSRTN GYLIHALMGS IISNLPSWIY LKIVMNMNKS
301 TRAHYLKKTK KNLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSD17B12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 3
- Mean surface accessibility (rSASA)
- 0.28
- Highest tissue expression
- 126 nTPM
Expression across tissuesHPA
Tissue
- parathyroid gland: 126 nTPM
- liver: 115 nTPM
- choroid plexus: 90 nTPM
- kidney: 85 nTPM
- heart muscle: 65 nTPM
- blood vessel: 65 nTPM
Single-cell type
- pancreatic islet cells: 429 nCPM
- choroid plexus epithelial cells: 291 nCPM
- distal convoluted tubule cells: 266 nCPM
- renal connecting tubule cells: 233 nCPM
- ependymal cells: 216 nCPM
- other brain neurons: 215 nCPM
Immune cell
- myeloid DC: 21 nTPM
- plasmacytoid DC: 18 nTPM
- NK-cell: 16 nTPM
- naive CD4 T-cell: 16 nTPM
- naive B-cell: 15 nTPM
- intermediate monocyte: 15 nTPM
Brain region
- choroid plexus: 136 nTPM
- cerebral cortex: 116 nTPM
- white matter: 111 nTPM
- pons: 109 nTPM
- medulla oblongata: 108 nTPM
- cerebellum: 107 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.9
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.65
- DepMap mean gene effect
- -0.39
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- estrogen biosynthetic process
- extracellular matrix organization
- fatty acid elongation, saturated fatty acid
- long-chain fatty-acyl-CoA biosynthetic process
- positive regulation of cell-substrate adhesion
Molecular functions
- collagen binding
- estradiol 17-beta-dehydrogenase [NAD(P)+] activity
- fibronectin binding
- heparin binding
- oxidoreductase activity
- very-long-chain 3-oxoacyl-CoA reductase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HSD17B12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSD17B12 as an antibody target. Whether an autoantibody or antibody against HSD17B12 could matter depends on whether native HSD17B12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSD17B12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label HSD17B12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...